×
About 14,666 results

ALLMedicine™ Attention Deficit Hyperactivity Disorder Center

Research & Reviews  6,703 results

Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake I...
https://doi.org/10.2174/1570159X19666210303121059
Current Neuropharmacology; Leshem R, Bar-Oz B et. al.

Mar 3rd, 2021 - An inconsistent association between exposure to SSRIs and SNRIs and the risk for ASD and ADHD in the Offspring was observed in observational studies. Some suggest that the reported association might be due to unmeasured confounding. We aimed to st...

Structural brain network topology underpinning ADHD and response to methylphenidate tre...
https://doi.org/10.1038/s41398-021-01278-x 10.1176/appi.ajp.2012.11101521 10.1016/j.tics.2011.11.007 10.1017/S003329171900237X 10.1002/hbm.22504 10.1080/87565641.2013.783833 10.1016/j.biopsych.2004.11.047 10.1016/j.pscychresns.2015.02.009 10.1016/j.neubiorev.2012.01.003 10.1111/jcpp.12379 10.1371/journal.pcbi.0010042 10.1371/journal.pcbi.0030017 10.1038/nrn2575 10.1007/s12035-014-8685-x 10.1016/j.neuroimage.2010.01.071 10.1523/JNEUROSCI.4793-12.2013 10.1016/j.biopsych.2013.12.013 10.1007/s11682-016-9559-9 10.1016/j.biopsych.2010.07.003 10.1038/npp.2013.27 10.1016/j.neuropharm.2009.08.013 10.1007/s11682-016-9620-8 10.1038/74737 10.1089/cap.2015.0243 10.1097/00004583-199610000-00017 10.1016/j.jaac.2017.04.005 10.1192/bjp.bp.113.140376 10.1093/brain/awt310 10.1016/j.jad.2014.11.010 10.1177/1087054714543924 10.1002/hbm.23401 10.5694/j.1326-5377.2001.tb143503.x 10.1016/j.neuroimage.2009.10.003 10.1152/jn.00338.2011 10.1016/j.jeconom.2015.02.006 10.18637/jss.v028.i05 10.18637/jss.v011.i09 10.1016/S0006-3223(02)01904-2 10.1016/j.pscychresns.2008.07.003 10.3109/00048679109077746 10.1016/S0960-9822(00)00593-5 10.1038/sj.npp.1301164 10.1523/JNEUROSCI.4465-11.2011 10.1016/j.neuron.2008.04.017 10.1073/pnas.1601745113 10.1038/s41467-017-01285-x 10.1038/s41598-020-64124-y 10.1002/cne.902280110 10.1016/j.jaac.2014.05.001 10.1038/s41380-019-0574-2 10.3171/2013.2.JNS121294 10.1016/j.euroneuro.2016.02.007 10.1016/j.nicl.2019.101851
Translational Psychiatry; Griffiths KR, Braund TA et. al.

Mar 3rd, 2021 - Behavioural disturbances in attention deficit hyperactivity disorder (ADHD) are thought to be due to dysfunction of spatially distributed, interconnected neural systems. While there is a fast-growing literature on functional dysconnectivity in ADH...

Dual diagnosis of type 1 diabetes mellitus and attention deficit hyperactivity disorder.
https://doi.org/10.1111/pedi.13195
Pediatric Diabetes; Mazor-Aronovitch K, Pinhas-Hamiel O et. al.

Mar 2nd, 2021 - Data regarding glycemic control in children and adolescents with a dual diagnosis of type 1 diabetes mellitus (T1DM) and attention-deficit/hyperactivity disorder (ADHD) are limited. To compare various aspects of diabetes control among youth with T...

A co-twin-control study of altered sensory processing in autism.
https://doi.org/10.1177/1362361321991255
Autism : the International Journal of Research and Practice; Neufeld J, Taylor MJ et. al.

Mar 1st, 2021 - Individuals diagnosed with autism often describe that they process sensory information differently from others, and many experience sensory issues as problematic. For instance, an increased sensitivity to smells or sounds can make participating in...

Investigating the Measurement Invariance and Method-Trait Effects of Parent and Teacher...
https://doi.org/10.1007/s10578-021-01145-2 10.1016/S0140-6736(19)33004-1 10.1111/jcpp.12150 10.1016/j.euroneuro.2018.08.001 10.1111/j.1469-7610.2007.01733.x 10.3389/978-2-88919-650-0 10.1037/a0013219 10.1037/1082-989X.8.1.38 10.1037/h0046016 10.1097/00004583-200102000-00011 10.1177/1073191107313888 10.1002/mpr.237 10.1016/j.braindev.2013.09.003 10.1016/j.jped.2018.06.014 10.1037/a0020975 10.1177/1073191119842255 10.1007/s10802-018-0434-6 10.1177/1073191116660381 10.1037/pas0000008 10.1007/s00406-011-0288-1 10.1007/s10802-012-9641-8 10.1007/s10802-012-9660-5 10.1111/jcpp.12505 10.1176/appi.ajp.161.11.2014 10.1111/jcpp.12010 10.1111/jcpp.12737 10.1590/S0101-81082006000300008 10.3389/fpsyg.2014.01216 10.1348/000711005X67490 10.1037/met0000075 10.1207/S15327906MBR3903_4 10.1177/109442810032003 10.1207/S15328007SEM0902_1 10.1037/a0033266 10.1080/10705519909540118 10.1080/00220973.2010.531299 10.1177/1073191119858421 10.1016/j.ridd.2016.05.002 10.1080/15374411003691743 10.1111/j.1469-7610.2009.02091.x 10.1027/1015-5759/a000435 10.1007/s10802-012-9660-5 10.1080/15374416.2015.1118693 10.1007/s10802-019-00608-4
Child Psychiatry and Human Development; Lúcio PS, Eid M et. al.

Feb 27th, 2021 - The Swanson, Nolan, and Pelham scale version IV (SNAP-IV) is widely used to assess symptoms of attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) in children and adolescents. Nevertheless, there is insufficient...

see more →

Guidelines  13 results

Comparable emotional dynamics in women with ADHD and borderline personality disorder
https://bpded.biomedcentral.com/articles/10.1186/s40479-021-00144-y
Borderline Personality Disorder and Emotion Dysregulation; Moukhtarian TR

Feb 11th, 2021 - Emotional dysregulation (ED) is a core diagnostic symptom in borderline personality disorder (BPD) and an associated feature of attention-deficit/hyperactivity disorder (ADHD). We aimed to investigate differences in dynamical indices of ED in dail...

Adult attention deficit hyperactivity disorder in patients with fibromyalgia syndrome: Assessment and disabilities
https://pubmed.ncbi.nlm.nih.gov/33127072/
Journal of Psychiatric Research; Stefano P

Oct 23rd, 2020 - In the broader list of cognitive concerns, neuropsychological testing has shown that attentional impairment may have a specific burden in Fibromyalgia Syndrome (FMS).

Adhansia XR Approved for the Treatment of Pediatric, Adult ADHD
https://www.empr.com/home/news/adhansia-xr-approved-for-the-treatment-of-pediatric-adult-adhd/

Feb 28th, 2019 - The Food and Drug Administration (FDA) has approved Adhansia XR (methylphenidate HCl extended-release; Adlon Therapeutics), a central nervous system stimulant, for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 year...

ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-...
https://www.aafp.org/patient-care/clinical-recommendations/all/ADHD.html
American Academy of Family Physicians

Apr 30th, 2016 - Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood and can profoundly affect the academic achievement, well-being, and social interactions of children, the American Academy of Pediatrics first.

see more →

Drugs  411 results see all →

Clinicaltrials.gov  7,319 results

Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake I...
https://doi.org/10.2174/1570159X19666210303121059
Current Neuropharmacology; Leshem R, Bar-Oz B et. al.

Mar 3rd, 2021 - An inconsistent association between exposure to SSRIs and SNRIs and the risk for ASD and ADHD in the Offspring was observed in observational studies. Some suggest that the reported association might be due to unmeasured confounding. We aimed to st...

Structural brain network topology underpinning ADHD and response to methylphenidate tre...
https://doi.org/10.1038/s41398-021-01278-x 10.1176/appi.ajp.2012.11101521 10.1016/j.tics.2011.11.007 10.1017/S003329171900237X 10.1002/hbm.22504 10.1080/87565641.2013.783833 10.1016/j.biopsych.2004.11.047 10.1016/j.pscychresns.2015.02.009 10.1016/j.neubiorev.2012.01.003 10.1111/jcpp.12379 10.1371/journal.pcbi.0010042 10.1371/journal.pcbi.0030017 10.1038/nrn2575 10.1007/s12035-014-8685-x 10.1016/j.neuroimage.2010.01.071 10.1523/JNEUROSCI.4793-12.2013 10.1016/j.biopsych.2013.12.013 10.1007/s11682-016-9559-9 10.1016/j.biopsych.2010.07.003 10.1038/npp.2013.27 10.1016/j.neuropharm.2009.08.013 10.1007/s11682-016-9620-8 10.1038/74737 10.1089/cap.2015.0243 10.1097/00004583-199610000-00017 10.1016/j.jaac.2017.04.005 10.1192/bjp.bp.113.140376 10.1093/brain/awt310 10.1016/j.jad.2014.11.010 10.1177/1087054714543924 10.1002/hbm.23401 10.5694/j.1326-5377.2001.tb143503.x 10.1016/j.neuroimage.2009.10.003 10.1152/jn.00338.2011 10.1016/j.jeconom.2015.02.006 10.18637/jss.v028.i05 10.18637/jss.v011.i09 10.1016/S0006-3223(02)01904-2 10.1016/j.pscychresns.2008.07.003 10.3109/00048679109077746 10.1016/S0960-9822(00)00593-5 10.1038/sj.npp.1301164 10.1523/JNEUROSCI.4465-11.2011 10.1016/j.neuron.2008.04.017 10.1073/pnas.1601745113 10.1038/s41467-017-01285-x 10.1038/s41598-020-64124-y 10.1002/cne.902280110 10.1016/j.jaac.2014.05.001 10.1038/s41380-019-0574-2 10.3171/2013.2.JNS121294 10.1016/j.euroneuro.2016.02.007 10.1016/j.nicl.2019.101851
Translational Psychiatry; Griffiths KR, Braund TA et. al.

Mar 3rd, 2021 - Behavioural disturbances in attention deficit hyperactivity disorder (ADHD) are thought to be due to dysfunction of spatially distributed, interconnected neural systems. While there is a fast-growing literature on functional dysconnectivity in ADH...

Dual diagnosis of type 1 diabetes mellitus and attention deficit hyperactivity disorder.
https://doi.org/10.1111/pedi.13195
Pediatric Diabetes; Mazor-Aronovitch K, Pinhas-Hamiel O et. al.

Mar 2nd, 2021 - Data regarding glycemic control in children and adolescents with a dual diagnosis of type 1 diabetes mellitus (T1DM) and attention-deficit/hyperactivity disorder (ADHD) are limited. To compare various aspects of diabetes control among youth with T...

A co-twin-control study of altered sensory processing in autism.
https://doi.org/10.1177/1362361321991255
Autism : the International Journal of Research and Practice; Neufeld J, Taylor MJ et. al.

Mar 1st, 2021 - Individuals diagnosed with autism often describe that they process sensory information differently from others, and many experience sensory issues as problematic. For instance, an increased sensitivity to smells or sounds can make participating in...

Guanfacine - guanfacine tablet, extended release-Sun Pharmaceutical Industries, Inc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d0a0f8e-5098-4ee2-a4ee-d026789923e2

Feb 28th, 2021 - Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14)]. Guanfacine extended-release table...

see more →

News  215 results

Strep A and Tic Worsening: Final Word?
https://www.medscape.com/viewarticle/945720

Feb 11th, 2021 - Exposure to Group A streptococcus (GAS) does not appear to worsen symptoms of Tourette syndrome and other chronic tic disorders (CTDs) in children and adolescents, new research suggests. Investigators studied over 700 children and teenagers with C...

Comparable emotional dynamics in women with ADHD and borderline personality disorder
https://bpded.biomedcentral.com/articles/10.1186/s40479-021-00144-y
Borderline Personality Disorder and Emotion Dysregulation; Moukhtarian TR

Feb 11th, 2021 - Emotional dysregulation (ED) is a core diagnostic symptom in borderline personality disorder (BPD) and an associated feature of attention-deficit/hyperactivity disorder (ADHD). We aimed to investigate differences in dynamical indices of ED in dail...

Brain Connectivity Patterns Reliably Identify ADHD
https://www.medscape.com/viewarticle/945305

Feb 7th, 2021 - Functional brain connectivity patterns are a stable biomarker of attention deficit hyperactivity disorder (ADHD), new research suggests. By applying a machine-learning approach to brain imaging data, investigators were able to identify with 99% ac...

ADHD Meds May Boost Treatment Retention in Comorbid Addiction
https://www.medscape.com/viewarticle/942697

Dec 14th, 2020 - Judicious use of stimulants may help patients with attention deficit hyperactivity disorder (ADHD) and comorbid substance use disorder (SUD) stay in addiction treatment programs, new research shows. Results of a 5-year retrospective cohort study s...

Adult attention deficit hyperactivity disorder in patients with fibromyalgia syndrome: Assessment and disabilities
https://pubmed.ncbi.nlm.nih.gov/33127072/
Journal of Psychiatric Research; Stefano P

Oct 23rd, 2020 - In the broader list of cognitive concerns, neuropsychological testing has shown that attentional impairment may have a specific burden in Fibromyalgia Syndrome (FMS).

see more →

Patient Education  5 results see all →